Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study

SIMPLE SUMMARY: The efficacy and safety of oxaliplatin-based regimens in late-care settings have been poorly reported. In 119 mCRC patients, the oxaliplatin retreatment response rate (RR) was 21.6%. The median progression-free survival was 5.1 months. A total of 34/119 (28.6%) discontinued treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Amatu, Alessio, Mauri, Gianluca, Tosi, Federica, Bencardino, Katia, Bonazzina, Erica, Gori, Viviana, Ruggieri, Lorenzo, Arena, Sabrina, Bardelli, Alberto, Marsoni, Silvia, Siena, Salvatore, Sartore-Bianchi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909235/
https://www.ncbi.nlm.nih.gov/pubmed/35267504
http://dx.doi.org/10.3390/cancers14051197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909235/
https://www.ncbi.nlm.nih.gov/pubmed/35267504
http://dx.doi.org/10.3390/cancers14051197

Ejemplares similares